{"text_format":"2","workbook":"xlsx","n_sheets":1,"sheets":["Sheet1"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Sheet1","index":0,"n_rows":31,"n_cols":12,"rows_kept":31,"cut":false,"hidden":false,"merged":[]}
["Institution","Abstract Title","Topic","Presenter First Name","Presenter Last Name","Authors","Abstract Number","Session Title","Session Type","Session Date","Session Start","Session End"]
["Yale School of Medicine","Survival Comparison of 3 Versus 4-5 Fractions for Stereotactic Body Radiation Therapy in Stage I Non-Small Cell Lung Cancer","Lung","Henry","Park","H. S. M. Park, C. D. Corso, C. E. Rutter, A. W. Kim, J. B. Yu, Z. A. Husain, and R. H. Decker; Yale School of Medicine, New Haven, CT",227,"Lung V: SBRT","Oral","2015-10-20","16:45:00","18:15:00"]
["Yale School of Medicine","Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer","Health Services Research","Nataniel","Lester-Coll","N. H. Lester-Coll1, H. S. M. Park1, C. E. Rutter1, C. D. Corso1, B. R. Mancini1, D. N. Yeboa1, S. Kim2, C. P. Gross3, and J. B. Yu4; 1Yale School of Medicine, New Haven, CT, 2Case Western Reserve University School of Medicine, Cleveland, OH, 3Yale University School of Medicine, New Haven, CT, 4Yale University, New Haven, CT",268,"Health Services Research II","Oral","2015-10-21","10:45:00","12:15:00"]
["Yale School of Medicine","The Addition of Radiation Therapy to Adjuvant Chemotherapy is Associated With Improved Overall Survival in Resected Pancreatic Adenocarcinoma","Gastrointestinal","Charles","Rutter","C. E. Rutter1, H. S. M. Park1, C. D. Corso1, N. H. Lester-Coll1, B. R. Mancini1, D. N. Yeboa1, and K. L. Johung2; 1Yale School of Medicine, New Haven, CT, 2Yale University School of Medicine, New Haven, CT",353,"GI VI - Pancreatic Cancer - Current Treatment Approaches","Oral","2015-10-21","15:00:00","16:30:00"]
["Yale School of Medicine","Stereotactic Body Radiation Therapy Versus Conventionally Fractionated Radiation Therapy: A Propensity Score Matched Analysis of Survival in Unresected Pancreatic Cancer","Gastrointestinal","Christopher","Corso","C. D. Corso1, H. S. M. Park1, C. E. Rutter1, N. H. Lester-Coll1, B. R. Mancini1, D. N. Yeboa1, and K. L. Johung2; 1Yale School of Medicine, New Haven, CT, 2Yale University School of Medicine, New Haven, CT",355,"GI VI - Pancreatic Cancer - Current Treatment Approaches","Oral","2015-10-21","15:00:00","16:30:00"]
["Yale School of Medicine","The Role of Chemoradiation in Elderly Limited-Stage Small Cell Lung Cancer Patients","Lung","Roy","Decker","C. D. Corso, C. E. Rutter, H. S. M. Park, N. H. Lester-Coll, Z. A. Husain, and R. H. Decker; Yale School of Medicine, New Haven, CT",1010,"Lung I: Locally Advanced Small Cell","ePoster","2015-10-18","13:15:00","14:45:00"]
["Yale School of Medicine","Concurrent Chemoradiation Therapy Is Associated With Improved Survival Compared to Radiation Therapy Alone for Anaplastic Gliomas","CNS","Debra","Yeboa","D. N. Yeboa, C. E. Rutter, H. S. M. Park, N. H. Lester-Coll, C. D. Corso, B. R. Mancini, R. S. Bindra, and J. B. Yu; Yale School of Medicine, New Haven, CT",1029,"CNS I - Benign and Intermediate Risk CNS Tumors; Controversies in High Grade Glioma","ePoster","2015-10-18","16:45:00","18:15:00"]
["Yale School of Medicine","Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung Cancer","Lung","Henry","Park","H. S. M. Park, E. H. Wang, C. D. Corso, C. E. Rutter, L. D. Wilson, A. W. Kim, C. P. Gross, J. B. Yu, and R. H. Decker; Yale School of Medicine, New Haven, CT",1073,"Lung III: SBRT (Miscellaneous)","ePoster","2015-10-20","13:00:00","14:30:00"]
["Yale School of Medicine","Postmastectomy Radiation Therapy for Women With 1-3 Positive Axillary Lymph Nodes: A Patterns of Care Analysis","Breast","Henry","Park","H. S. M. Park1, C. E. Rutter1, Y. An2, B. K. Killelea3, and S. B. Evans2; 1Yale School of Medicine, New Haven, CT, 2Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, 3Department of Surgery, Yale School of Medicine, New Haven, CT",2012,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Shifts in Stereotactic Radiosurgery Platform Utilization for Brain Metastases in the United States","CNS","Henry","Park","H. S. M. Park1, E. H. Wang1, C. E. Rutter1, C. D. Corso1, V. L. Chiang2, and J. B. Yu1; 1Yale School of Medicine, New Haven, CT, 2Yale University School of Medicine, New Haven, CT",2154,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Spine Stereotactic Body Radiation Therapy Outcomes in Patients With Concurrent Brain Metastases","CNS","Henry","Park","H. S. M. Park1, R. J. Colaco2, M. S. Laurans3, V. L. Chiang4, J. B. Yu1, and Z. A. Husain1; 1Yale School of Medicine, New Haven, CT, 2Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, 3Department of Neurosurgery, Yale School of Medicine, New Haven, CT, 4Yale University School of Medicine, New Haven, CT",2155,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Practice Patterns of Concurrent Chemoradiation Therapy Compared to Radiation Therapy Alone for Low Grade Gliomas","CNS","Debra","Yeboa","D. N. Yeboa, H. S. M. Park, C. E. Rutter, B. R. Mancini, C. D. Corso, N. H. Lester-Coll, R. S. Bindra, and J. B. Yu; Yale School of Medicine, New Haven, CT",2183,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Genomic Predictors of Biochemical Failure Following Radical Prostatectomy","Genitourinary","Sanjay","Aneja","S. Aneja1, C. P. Gross2, P. M. Glazer3, and J. B. Yu1; 1Yale School of Medicine, New Haven, CT, 2Yale University School of Medicine, New Haven, CT, 3Yale University, New Haven, CT, United States",2625,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Influence of Robotic Hysterectomy on Delayed Vaginal Cuff Healing and Brachytherapy Initiation in Endometrial Carcinoma Patients","Gynecologic","John","Stahl","J. M. Stahl, H. S. M. Park, and S. Damast; Yale School of Medicine, New Haven, CT",2637,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","mRNA Expression of TP53 Attenuates Survival of HPV+ Locally Advanced Head and Neck Cancer","Head and Neck","Sanjay","Aneja","S. Aneja1, J. N. Contessa2, Z. A. Husain1, P. M. Glazer3, J. E. Hansen3, R. S. Bindra1, and J. B. Yu1; 1Yale School of Medicine, New Haven, CT, 2Yale University School of Medicine, New Haven, CT, 3Yale University, New Haven, CT, United States",2871,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Trends in Hospital Owned Practices Within Radiation Oncology","Health Services Research","Sanjay","Aneja","S. Aneja1, B. D. Smith2, C. P. Gross3, B. G. Haffty4, L. D. Wilson1, and J. B. Yu1; 1Yale School of Medicine, New Haven, CT, 2MD Anderson Cancer Center, Houston, TX, 3Yale University School of Medicine, New Haven, CT, 4Rutgers Cancer Institute of New Jersey, New Brunswick, NJ",2926,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Initial Experience With #radonc: An International Online Monthly Radiation Oncology Journal Club","History & Education in Radiation Oncology","Zain","Husain","Z. A. Husain1, B. R. Mancini1, I. Periera2,3, M. A. Knoll4, and M. S. Katz5; 1Yale School of Medicine, New Haven, CT, 2Cancer Centre of Southeastern Ontario, Kingston General Hospital, Kingston, ON, Canada, 3Queens University, KIngston, ON, Canada, 4Mount Sinai Medical Center, NY, NY, 5Radiation Oncology Associates PA, Lowell, MA",2934,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Association Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung Cancer","Lung","Elyn","Wang","E. H. Wang1, C. Corso2, H. S. M. Park1, A. B. Chen3, A. W. Kim1, L. D. Wilson1, R. H. Decker1, and J. B. Yu1; 1Yale School of Medicine, New Haven, CT, 2Yale University, New Haven, CT, United States, 3Dana-Farber Cancer Institute, Boston, MA",2966,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small Cell Lung Cancer","Lung","Elyn","Wang","E. H. Wang1, C. Corso2, C. E. Rutter1, H. S. M. Park1, A. B. Chen3, A. W. Kim1, L. D. Wilson1, R. H. Decker1, and J. B. Yu1; 1Yale School of Medicine, New Haven, CT, 2Yale University, New Haven, CT, United States, 3Dana-Farber Cancer Institute, Boston, MA",2968,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Trends In The Utilization Of Radiation Therapy For Early-Stage Low Grade Follicular Lymphoma: The Impact Of \"Watchful Waiting\" Evidence On Clinical Practice","Lymphoma/Leukemia/Hematologic","Sanjay","Aneja","S. Aneja, L. D. Wilson, and J. B. Yu; Yale School of Medicine, New Haven, CT",3153,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","Pediatric Brainstem Glioma Survival After Definitive Radiation Therapy With or Without Concurrent Chemotherapy: A Nationwide Comparison","Pediatrics","Henry","Park","H. S. M. Park, D. N. Yeboa, N. H. Lester-Coll, C. D. Corso, B. R. Mancini, R. S. Bindra, K. B. Roberts, J. B. Yu, and C. E. Rutter; Yale School of Medicine, New Haven, CT",3261,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale School of Medicine","The Effect of Margin Status and Radiation Therapy on Survival in Adult Retroperitoneal Soft Tissue Sarcomas","Sarcoma and Cutaneous Tumors","John","Stahl","J. M. Stahl1, C. D. Corso1, Y. An2, S. Aneja1, C. E. Rutter1, H. S. M. Park1, B. R. Mancini1, D. N. Yeboa1, N. H. Lester-Coll1, D. Han3, and K. B. Roberts1; 1Yale School of Medicine, New Haven, CT, 2Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, 3Yale Department of Surgical Oncology, New Haven, CT",3599,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","5:00 PM\n3:00 PM"]
["Yale University","Scientific Discussant",null,"Susan","Higgins","S. Higgins; Yale University, New Haven, CT, United States",null,"GYN II","ePoster","2015-10-20","16:45:00","18:15:00"]
["Yale University","Nanoparticle Enhanced Focused Kv X-ray Radiation Therapy","Radiation Physics","Wu","Liu","W. Liu1, C. MacDonald2, H. Abbas3, R. Nath1, and Z. Chen1; 1Yale University, New Haven, CT, 2University at Albany - SUNY, Albany, NY, 3Ellis Hospital, Schenectady, NY",334,"Physics XIII - Innovative Planning and Delivery Strategies","Oral","2015-10-21","15:00:00","16:30:00"]
["Yale University School of Medicine","Identification and Characterization of Novel DNA Repair Inhibitors as Potential Tumor Cell Radiosensitizers","Radiation and Cancer Biology","Vikram","Jairam","V. Jairam1, R. K. Sundaram1, G. Breuer1, Y. Surovtseva2, and R. S. Bindra3; 1Yale University School of Medicine, New Haven, CT, 2Yale Center for Molecular Discovery, New Haven, CT, 3Yale School of Medicine, New Haven, CT",106,"Biology I-Radiosensitizers","Oral","2015-10-19","10:45:00","12:15:00"]
["Yale University School of Medicine","Extended Survival and Prognostic Factors for Patients With ALK Rearranged NSCLC and Brain Metastasis","CNS","Kimberly","Johung","K. L. Johung1, N. Yeh2, N. B. Desai3, T. M. Williams4, T. Lautenschlaeger4, N. D. Arvold5, M. Ning6, A. Attia7, C. M. Lovly6, S. Goldberg1, K. Beal3, J. B. Yu8, B. D. Kavanagh2, V. L. Chiang1, D. R. Camidge9, and J. N. Contessa1; 1Yale University School of Medicine, New Haven, CT, 2University of Colorado Comprehensive Cancer Center, Aurora, CO, 3Memorial Sloan Kettering Cancer Center, New York, NY, 4Ohio State University, Columbus, OH, 5Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, 6Vanderbilt University School of Medicine, Nashville, TN, 7Vanderbilt University Medical Center, Nashville, TN, 8Yale School of Medicine, New Haven, CT, 9University of Colorado, Aurora, CO",1050,"CNS III - Competing Risks in the CNS: Control, Toxicity and Long Term Survivors","ePoster","2015-10-19","10:45:00","12:15:00"]
["Yale University School of Medicine","Molecular Characteristics and Overall Survival for Grade III Gliomas","CNS","Vikram","Jairam","V. Jairam1, C. E. Rutter2, J. B. Yu2, J. N. Contessa3, and R. S. Bindra2; 1Yale University School of Medicine, New Haven, CT, 2Yale School of Medicine, New Haven, CT, 3Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT",2140,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale University School of Medicine","Factors Associated With High-Volume Providers of Stereotactic Radiation Therapy for Medicare Beneficiaries in 2012","Health Services Research","Sean","Maroongroge","S. Maroongroge1,2, H. S. M. Park2,3, C. E. Rutter2,3, R. H. Decker2,3, and J. B. Yu2,3; 1Yale University School of Medicine, New Haven, CT, 2Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, 3Yale School of Medicine, New Haven, CT",2875,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale University School of Medicine","Minimally Invasive Surgery and External Beam Radiation Therapy Selection for Prostate Cancer Varies Significantly by Health Insurance Status","Health Services Research","Trevor","Bledsoe","T. J. Bledsoe1,2, H. S. M. Park2,3, C. E. Rutter2,3, S. Aneja3, and J. B. Yu2,3; 1Yale University School of Medicine, New Haven, CT, 2Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, 3Yale School of Medicine, New Haven, CT",2893,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale University School of Medicine","Stereotactic Body Radiation Therapy for Prostate Cancer: Adoption in the United States From 2005 to 2012","Health Services Research","Trevor","Bledsoe","T. J. Bledsoe1,2, C. E. Rutter2,3, C. D. Corso3, S. Aneja3, N. H. Lester-Coll3, E. H. Wang3, A. Potosky4, C. P. Gross3, J. B. Yu2,3, and H. S. M. Park2,3; 1Yale University School of Medicine, New Haven, CT, 2Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, 3Yale School of Medicine, New Haven, CT, 4Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC",2894,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]
["Yale University School of Medicine","Pulmonary Dose Volume Predictors of Radiation Pneumonitis After Stereotactic Body Radiation Therapy","Lung","Eileen","Harder","E. M. Harder1, H. S. M. Park2, Z. Chen3, and R. H. Decker2; 1Yale University School of Medicine, New Haven, CT, 2Yale School of Medicine, New Haven, CT, 3Yale University, New Haven, CT",3063,"Poster Viewing","Poster Viewing","10/18/2015\n10/19/2015\n10/20/2015","10:00:00","17:00:00"]